rs747922027
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001159699.2(FHL1):c.856C>G(p.Gln286Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,208,982 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001159699.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHL1 | NM_001159699.2 | c.856C>G | p.Gln286Glu | missense_variant | 6/6 | ENST00000370683.6 | NP_001153171.1 | |
FHL1 | NM_001159702.3 | c.*36C>G | 3_prime_UTR_variant | 8/8 | ENST00000394155.8 | NP_001153174.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHL1 | ENST00000370683.6 | c.856C>G | p.Gln286Glu | missense_variant | 6/6 | 1 | NM_001159699.2 | ENSP00000359717.1 | ||
FHL1 | ENST00000394155.8 | c.*36C>G | 3_prime_UTR_variant | 8/8 | 5 | NM_001159702.3 | ENSP00000377710.2 |
Frequencies
GnomAD3 genomes AF: 0.0000181 AC: 2AN: 110774Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32978
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183530Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67960
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1098208Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 363562
GnomAD4 genome AF: 0.0000181 AC: 2AN: 110774Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32978
ClinVar
Submissions by phenotype
X-linked myopathy with postural muscle atrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 04, 2023 | This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 270 of the FHL1 protein (p.Gln270Glu). This variant is present in population databases (rs747922027, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 565665). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2024 | The p.Q270E variant (also known as c.808C>G), located in coding exon 5 of the FHL1 gene, results from a C to G substitution at nucleotide position 808. The glutamine at codon 270 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on data from gnomAD, the G allele has an overall frequency of 0.001% (2/183530) total alleles studied, with no hemizygotes observed. The highest observed frequency was 0.015% (2/13161) of African alleles. Based on the available evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at